Business & Economy
Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
Source: Business News · Published
The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.
The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.
Related stories
New Flutter CEO bets on FanDuel promotions to win customers as profits suffer
Flutter's new CEO Dan Taylor issued his first earnings report as CEO on Wednesday.
Business News ·
Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
Business News ·
Physicl raises $10M to make the digital world real enough for robots
Physicl is trying to solve the sim-to-real gap with a pipeline originally built to market goods online.
TechCrunch ·
Harbinger raises $240M after expanding into defense
The Los Angeles-based startup has now raised more than $650 million, and is working on electric trucks, emergency vehicles, and a driverless platform for the military.
TechCrunch ·
Where's the growth? Legacy automakers face a tougher 2027 as costs rise, market tightens
Automakers are warning about higher commodity, logistics and memory costs, while pricing power is becoming harder to extend to consumers.
Business News ·